<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00731159</url>
  </required_header>
  <id_info>
    <org_study_id>54/08</org_study_id>
    <nct_id>NCT00731159</nct_id>
  </id_info>
  <brief_title>Sperm Capacitation Assay as a Tool to Predict Sperm Potential to Fertilize in IVF Treatment</brief_title>
  <official_title>Sperm Capacitation Assay as a Tool to Predict Sperm Potential to Fertilize in IVF Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assaf-Harofeh Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assaf-Harofeh Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our aim is to evaluate the potential of a new laboratory method that measure sperm
      capacitation to predict fertilization of oocytes in patients that undergo IVF treatments
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Capacitation is a physiologic process in which the sperm acquire the potential to fertilize
      oocytes. Capacitation can be measured, but the available technics are expensive, inaccurate
      and complex. A new method to evaluate sperm capacitation was developed in Bar Ilan
      University, Israel. We intend to measure the capacitation of semen that is used for
      fertilizing human oocytes in patients treated at the IVF unit at Assaf Harofeh Medical
      Center.By this, to evaluate the potential of the new method to predict human oocyte
      fertilization.If the method will be found valuable, it will enable to develop new
      drugs/methods that may improve sperm capacitation and by this to improve oocyte fertilization
      leading to more embryos, pregnancies and deliveries.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2008</start_date>
  <completion_date type="Anticipated">July 2009</completion_date>
  <primary_completion_date type="Anticipated">January 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fertilization rate of human oocytes in thr &quot;routine&quot; IVF Laboratory work</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Sperm Capacitation</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <description>Sperm capacitation:
Sperm capacitation is measured in a sample of the same ejaculated sperm unit given for fertilizing human oocytes in an IVF treatment cycle</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>sperm capacitation</intervention_name>
    <description>sperm capacitation measured at Bar Ilan University</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>biologic</intervention_name>
    <description>sperm synthesis of G-actine to F-actine</description>
    <arm_group_label>A</arm_group_label>
    <other_name>sperm capacitation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sperm capacitation</intervention_name>
    <description>sperm synthesis of G-actine to F-actine</description>
    <arm_group_label>A</arm_group_label>
    <other_name>sperm synthesis of G-actine to F-actine</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients requiring IVF within the &quot;routine&quot; work of an IVF Unit
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients requiring IVF within the &quot;routine&quot; work of an IVF Unit

          -  normo-responding woman

          -  non ICSI cycles

        Exclusion Criteria:

          -  Patients undergoing ICSI only cycle

          -  Low responders-less than 8 oocytes

          -  Male patients with low semen volume
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>arieh raziel, prof</last_name>
    <phone>97289779005</phone>
    <email>araziel@asaf.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>raphael ron-el, prof</last_name>
    <phone>97289779005</phone>
    <email>rronel@asaf.health.gov.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assaf Harofeh MC</name>
      <address>
        <city>Beer Yaacov</city>
        <state>Zerifin</state>
        <zip>70300</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>arieh raziel, prof</last_name>
      <phone>97289779005</phone>
      <email>araziel@asaf.health.gov.il</email>
    </contact>
    <contact_backup>
      <last_name>raphael ron-el, prof</last_name>
      <phone>97289779005</phone>
      <email>rronel@asaf.health.gov.il</email>
    </contact_backup>
    <investigator>
      <last_name>arieh raziel, prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>raphael ron-el, prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 7, 2008</study_first_submitted>
  <study_first_submitted_qc>August 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2008</study_first_posted>
  <last_update_submitted>August 7, 2008</last_update_submitted>
  <last_update_submitted_qc>August 7, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 8, 2008</last_update_posted>
  <responsible_party>
    <name_title>Prof A Raziel</name_title>
    <organization>Assaf Harofeh MC</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

